1-1 of 1
Sheila Schembri
Close
Sort by
Journal Articles

DDAVP at a Maximal Dose of 15 ug Administered Subcutaneously Is a Safe and Effective Alternative to 20 ug IV for Patients > 50 kg with von Willebrand Disease or Mild Hemophilia A.

Joy Mangel, Lori Laudenbach, Sheila Schembri, Lawrence Jardine, Reinhard Lohmann
Journal: Blood
Blood (2005) 106 (11): 1793.
https://doi.org/10.1182/blood.V106.11.1793.1793
Published: 2005